Considerations for the process development of insect-derived antimicrobial peptide production

Area of Science:

• Biotechnology
• Pharmacology
• Insect Science

Background:

• Antimicrobial peptides (AMPs) are crucial for developing new therapies against multi-resistant bacteria.
• Insects represent a rich source of AMPs, making their identification and characterization vital.
• Current challenges include developing cost-efficient, large-scale production methods for therapeutic applications.

Purpose of the Study:

• To review strategies for the large-scale production of insect-derived antimicrobial peptides (AMPs).
• To discuss the adaptation of existing protein expression knowledge for AMPs, considering their unique properties.
• To explore advanced purification techniques suitable for industrial-scale AMP manufacturing.

Main Methods:

• Review of existing literature on heterologous protein expression and AMP production.
• Analysis of challenges in upstream and downstream processing for AMPs.
• Evaluation of novel purification strategies, including elastin-like peptide/intein-based systems.

Main Results:

• Heterologous production is a viable option for AMPs, especially for peptides larger than 40 amino acids.
• AMPs present unique challenges in both upstream and downstream processing compared to larger proteins.
• The downstream process remains a significant bottleneck for cost-efficient, large-scale AMP production.

Conclusions:

• Insect-derived AMPs hold significant therapeutic potential against resistant bacteria.
• Optimizing expression systems and purification strategies is key to overcoming production bottlenecks.
• Focusing on cost-effective, large-scale manufacturing is essential for translating AMPs into viable drugs.